ZIVO Bioscience Inc. (ZIVO)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

ZIVO Bioscience Statistics

Share Statistics

ZIVO Bioscience has 3.55M shares outstanding. The number of shares has increased by 85% in one year.

Shares Outstanding 3.55M
Shares Change (YoY) n/a
Shares Change (QoQ) 2.66%
Owned by Institutions (%) n/a
Shares Floating 1.30M
Failed to Deliver (FTD) Shares 18
FTD / Avg. Volume 1.14%

Short Selling Information

The latest short interest is 35.47K, so 1% of the outstanding shares have been sold short.

Short Interest 35.47K
Short % of Shares Out 1%
Short % of Float 2.72%
Short Ratio (days to cover) 6.65

Valuation Ratios

The PE ratio is -0.26 and the forward PE ratio is -17.5.

PE Ratio -0.26
Forward PE -17.5
PS Ratio 73.35
Forward PS 46.6
PB Ratio -0.92
P/FCF Ratio -0.35
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

ZIVO Bioscience Inc. has an Enterprise Value (EV) of 2.16M.

EV / Earnings -0.28
EV / Sales 77.94
EV / EBITDA -0.3
EV / EBIT -0.3
EV / FCF -0.37

Financial Position

The company has a current ratio of 0.15, with a Debt / Equity ratio of -0.11.

Current Ratio 0.15
Quick Ratio 0.15
Debt / Equity -0.11
Total Debt / Capitalization -12.21
Cash Flow / Debt -24.17
Interest Coverage -14.13

Financial Efficiency

Return on equity (ROE) is 3.53% and return on capital (ROIC) is 390.59%.

Return on Equity (ROE) 3.53%
Return on Assets (ROA) -13.99%
Return on Capital (ROIC) 390.59%
Revenue Per Employee 3.46K
Profits Per Employee -972.15K
Employee Count 8
Asset Turnover 0.05
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 1596.58% in the last 52 weeks. The beta is 0.26, so ZIVO Bioscience 's price volatility has been higher than the market average.

Beta 0.26
52-Week Price Change 1596.58%
50-Day Moving Average 19.95
200-Day Moving Average 11.83
Relative Strength Index (RSI) 49.78
Average Volume (20 Days) 1.58K

Income Statement

In the last 12 months, ZIVO Bioscience had revenue of $27.65K and earned -$7.78M in profits. Earnings per share was $-4.6.

Revenue 27.65K
Gross Profit 11.61K
Operating Income -7.26M
Net Income -7.78M
EBITDA -7.26M
EBIT -7.26M
Earnings Per Share (EPS) -4.6
Full Income Statement

Balance Sheet

The company has $274.38K in cash and $346.34K in debt, giving a net cash position of -$71.96K.

Cash & Cash Equivalents 274.38K
Total Debt 346.34K
Net Cash -71.96K
Retained Earnings -123.58M
Total Assets 495.59K
Working Capital -2.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.80M and capital expenditures $0, giving a free cash flow of -$5.80M.

Operating Cash Flow -5.80M
Capital Expenditures 0
Free Cash Flow -5.80M
FCF Per Share -3.43
Full Cash Flow Statement

Margins

Gross margin is 41.99%, with operating and profit margins of -26.27K% and -28.13K%.

Gross Margin 41.99%
Operating Margin -26.27K%
Pretax Margin -28.13K%
Profit Margin -28.13K%
EBITDA Margin -26.27K%
EBIT Margin -26.27K%
FCF Margin -20.98K%

Dividends & Yields

ZIVO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -23.17%
FCF Yield -8.24%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ZIVO.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Oct 27, 2023. It was a backward split with a ratio of 1:6.

Last Split Date Oct 27, 2023
Split Type backward
Split Ratio 1:6

Scores

Altman Z-Score -467.03
Piotroski F-Score 2